“Overall and recurrence-free survival in patients with hepatocellular carcinoma awaiting liver transplantation after downstaging, bridging or no neoadjuvant therapy”
This portal gives access to the HCC- ET trial database.
To go to the webform logon page, click HERE.
Don't forget to sent the pathology report of the liver explant:
S.Y. Marks, Medical Staff
Eurotransplant International Foundation
P.O. Box 2304, NL
2301 CH, Leiden, The Netherlands
Or by fax: +31 71 5790057